International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people
C Gimpel, C Bergmann, D Bockenhauer… - Nature Reviews …, 2019 - nature.com
These recommendations were systematically developed on behalf of the Network for Early
Onset Cystic Kidney Disease (NEOCYST) by an international group of experts in autosomal …
Onset Cystic Kidney Disease (NEOCYST) by an international group of experts in autosomal …
The approach to the patient with hematuria
GC Willis, SZ Tewelde - Emergency Medicine Clinics, 2019 - emed.theclinics.com
Background The definition of hematuria is the excretion of red blood cells (RBCs) in the
urine. A problem arising in the genitourinary tract anywhere from the glomerulus to the …
urine. A problem arising in the genitourinary tract anywhere from the glomerulus to the …
Novel mutations in the PKD1 and PKD2 genes of Chinese patients with autosomal dominant polycystic kidney disease
D Xu, Y Ma, X Gu, R Bian, Y Lu, X Xing… - Kidney and Blood …, 2018 - karger.com
Abstract Background/Aims: Autosomal dominant polycystic kidney disease (ADPKD) is the
most common inherited kidney disorder with mutations in PKD1 or PKD2. This study aimed …
most common inherited kidney disorder with mutations in PKD1 or PKD2. This study aimed …
Systematic review of hematuria and acute renal failure with tranexamic acid
SG Lee, J Fralick, CJD Wallis, M Boctor… - European Journal of …, 2022 - Wiley Online Library
Objectives To conduct a systematic review of tranexamic acid (TXA) and the risk of renal
failure from urinary clots in adult patients with hematuria. Methods A systematic review of …
failure from urinary clots in adult patients with hematuria. Methods A systematic review of …
The association between autosomal dominant polycystic kidney disease and cancer
K Sun, D Xu, C Mei - International urology and nephrology, 2019 - Springer
Autosomal dominant polycystic kidney disease (ADPKD) is considered as a tumor-like
disease because there are many biological similarities between ADPKD and cancer …
disease because there are many biological similarities between ADPKD and cancer …
The effects of tranexamic acid on bleeding control during and after percutaneous nephrolithotomy (PCNL): a randomized clinical trial
MR Mokhtari, S Farshid, P Modresi, F Abedi - Urology journal, 2021 - journals.sbmu.ac.ir
Purpose: Tranexamic acid is a fibrinolysis suppressor that is used for a variety of bleeding
control procedures such as hematuria, surgery bleeding, and trauma caused bleeding. The …
control procedures such as hematuria, surgery bleeding, and trauma caused bleeding. The …
Composite hemostatic nonwoven textiles based on hyaluronic acid, cellulose, and etamsylate
P Suchý, A Paprskářová, M Chalupová, L Marholdová… - Materials, 2020 - mdpi.com
The achievement of rapid hemostasis represents a long-term trend in hemostatic research.
Specifically, composite materials are now the focus of attention, based on the given issues …
Specifically, composite materials are now the focus of attention, based on the given issues …
The role of tranexamic acid in the management of an acutely hemorrhaging patient
S Davis, A Nawab, C van Nispen… - Hospital …, 2021 - journals.sagepub.com
Background: Acute hemorrhage, both traumatic and nontraumatic, leads to significant
morbidity and mortality, both in the United States and globally. Traditional treatment of acute …
morbidity and mortality, both in the United States and globally. Traditional treatment of acute …
[HTML][HTML] Safety and efficacy of transcatheter arterial embolization in autosomal dominant polycystic kidney patients with gross hematuria: Six case reports
WF Sui, YX Duan, JY Li, WB Shao… - World Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Safety and efficacy of transcatheter arterial embolization in autosomal dominant polycystic
kidney patients with gross hematuria: Six case reports - PMC Back to Top Skip to main content …
kidney patients with gross hematuria: Six case reports - PMC Back to Top Skip to main content …
[PDF][PDF] 托伐普坦治疗快速进展型常染色体显性多囊肾病的临床实践指南解读
徐德超, 马熠熠, 梅长林 - 中华肾脏病杂志, 2019 - cjn.org.cn
常染色体显性多囊肾病(autosomal dominant polycystic kidney disease, ADPKD)
是最常见的单基因遗传性肾病. 近年来, 几项大型临床随机对照试验表明, 托伐普坦(tolvaptan) …
是最常见的单基因遗传性肾病. 近年来, 几项大型临床随机对照试验表明, 托伐普坦(tolvaptan) …